 |
| |
Medicated skin care was not fully developed in Bulgaria by the end of the review period, hence its moderate progress in 2009. There were a large number of products present which responded to varying needs but few of them held any particular influence over the category. Nizoral from Johnson & Johnson Bulgaria EOOD and Allergosan from Sopharma AD were the most popular brands . The success of these products was based largely on their traditional popularity; they have only been available for just a...
Medicated Skin Care Products in Bulgaria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Acne Treatments, Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Medicated Skin Care, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
We have over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, We have a unique capability to develop reliable information resources to help drive informed strategic planning.
Table of Contents
Medicated Skin Care in Bulgaria
May 2010
List of Contents and Tables
Executive Summary
Consumer Healthcare Largely Unaffected by the Recession
Educative Advertising Achieves Positive Result in Bulgarian Consumer Healthcare
Local Players Unable To Keep Up With Competition From Multinationals
Chemists/pharmacies Are the Main Distribution Channel, Despite the Existence of Drugstores and Direct Selling
Most Consumer Healthcare Categories Are Reaching Maturity
Key Trends and Developments
Chemists/pharmacies Remain the Leading Channel for Consumer Healthcare Products
Marketing and Advertising Campaigns Are Important for the Advance of Consumer Healthcare
Despite the Recession, Sales Levels Growth Is Still Positive
Nutritionals Still Register As Foods in Order To Avoid Strict Regulation
Rising Health Awareness Drives Vitamins and Dietary Supplements
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Definitions
Sector and Subsector Definitions
Summary 1 Research Sources
Borola Eood
Strategic Direction
Key Facts
Summary 2 Borola EOOD: Key Facts
Summary 3 Borola EOOD: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 4 Borola EOOD: Competitive Position 2009
Eurostok Bulgaria Eood
Strategic Direction
Key Facts
Summary 5 Eurostok Bulgaria EOOD: Key Facts
Summary 6 Eurostok Bulgaria EOOD: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Eurostok Bulgaria EOOD: Competitive Position 2009
Medika Ad
Strategic Direction
Key Facts
Summary 8 Medika AD: Key Facts
Summary 9 Medika AD: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Medika AD: Competitive Position 2009
Sopharma Ad
Strategic Direction
Key Facts
Summary 11 Sopharma AD: Key Facts
Summary 12 Sopharma AD: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 13 Sopharma AD: Competitive Position 2009
Terrachim - Nikolay Kostov Et
Strategic Direction
Key Facts
Summary 14 Terrachim - Nikolay Kostov: Key Facts
Summary 15 Terrachim - Nikolay Kostov: Operational Indicators
Company Background
Production
Competitive Positioning
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 11 Sales of Medicated Skin Care by Subsector: Value 2004-2009
Table 12 Sales of Medicated Skin Care by Subsector: % Value Growth 2004-2009
Table 13 Acne Treatments by Format: % Value Breakdown 2004-2009
Table 14 Medicated Skin Care Company Shares by Value 2005-2009
Table 15 Medicated Skin Care Brand Shares by Value 2006-2009
Table 16 Acne Treatments Brand Shares by Value 2006-2009
Table 17 Forecast Sales of Medicated Skin Care by Subsector: Value 2009-2014
Table 18 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2009-2014
Medicated Skin Care - Bulgaria - Market Report: http://www.companiesandmarkets.com/r.ashx?id=1BS9LLYDK300118&prk=398e20deaab364b3f3fb0b56ae670685
|
—
